#ScienceMadeSimple
LightNews LightNews
jessikadarkstar.bsky.social
E3: Are all stem cells the same?
My brain went straight to Pokémon, same category, wildly different abilities. Turns out stem cells really do have different “résumés.” 🧬 Keep digging into the research at AdiaMed.com.

#DarkstarDecodes #AdiaMed #StemCells #StemCellResearch #ScienceMadeSimple
September 24, 2026 at 5:39 PM
jessikadarkstar.bsky.social
E1: What even is a stem cell?

I went looking for the simple answer without getting buried under the science jargon. Keep digging into the research at AdiaMed.com.

#DarkstarDecodes #AdiaMed #StemCells #ScienceMadeSimple #ClinicalResearch
September 11, 2026 at 12:56 AM
lcrf.org
#ICYMI #ScienceMadeSimple #ASCO2026 - The plenary session of ASCO's 2026 annual meeting featured three presentations which could impact #LungCancer treatment. LCRF's Chief Scientific Officer, Dr. Toni Wozniak, explains what this means. LCRF.org/sms26ASCO
Work presented at ASCO meeting could impact lung cancer treatment - Lung Cancer Research Foundation
The good newsThree of the top five presentations at the plenary session of the annual ASCO meeting could potentially impact lung cancer treatment. These presentations typically spotlight major…
LCRF.org
July 2, 2026 at 7:26 PM
hippocrates-imi.bsky.social
📄 New Lay Summary: Finding Better Ways to Predict and Prevent Psoriatic Arthritis 🔬

📊 View the graphical abstract
🔗 Visit our website to read the full lay summary: hippocrates-imi.eu/publications...

#LaySummary #ScienceMadeSimple #Psoriasis #PsoriaticArthritis #biomarkers #omics
June 29, 2026 at 7:42 AM
hippocrates-imi.bsky.social
📄 New Lay Summary: Patient Voices Guide Prevention of Psoriatic Arthritis in HIPPOCRATES 💬

📊 View the graphical abstract
🔗 Visit our website to read the full lay summary: hippocrates-imi.eu/publications...

#LaySummary #ScienceMadeSimple #Psoriasis #PsoriaticArthritis
May 13, 2026 at 11:13 AM
hippocrates-imi.bsky.social
📄 New Lay Summary: Pain Patterns May Reveal Early Joint Inflammation in People with Psoriasis

📊 View the graphical abstract
🔗 Visit our website to read the full lay summary: hippocrates-imi.eu/publications...

#LaySummary #ScienceMadeSimple #Psoriasis #PsoriaticArthritis #AIinHealthcare
May 7, 2026 at 1:11 PM
lcrf.org
#ICYMI #ScienceMadeSimple - The FDA granted accelerated approval for zongertinib as a first-line treatment for HER2+ non-small cell #LungCancer. LCRF's Chief Scientific Officer, Dr. Toni Wozniak, unpacks what this means. LCRF.org/sms260424
Zongertinib approved as first-line HER2+ lung cancer treatment - Lung Cancer Research Foundation
The good news The U.S. Food and Drug Administration (FDA) has granted accelerated approval to zongertinib for the treatment of adult patients with metastatic non-squamous non-small cell lung cancer…
www.lungcancerresearchfoundation.org
May 1, 2026 at 3:15 PM
lcrf.org
2025 was a tremendous year for #LungCancer research. LCRF's Chief Scientific Officer, Antoinette Wozniak, MD, outlines the developments and what they mean going forward. #ScienceMadeSimple LCRF.org/hizrw
Lung cancer in 2025 - Lung Cancer Research Foundation
The good news I have been a Medical Oncologist for over 40 years, and I have had the privilege of witnessing an explosion of advancements in the treatment of lung […]
www.lungcancerresearchfoundation.org
January 29, 2026 at 7:53 PM
lcrf.org
#ScienceMadeSimple: FDA has granted accelerated approval to sevabertinib for treating HER2+ (ERBB2) #LungCancer. LCRF's Chief Scientific Officer, Dr. Toni Wozniak, explains what this means for patients. LCRF.org/sms25121
Sevabertinib for HER2+ lung cancer - Lung Cancer Research Foundation
The good news The U.S. Food and Drug Administration (FDA) has granted accelerated approval to sevabertinib for the treatment of adult patients with unresectable or metastatic non-squamous non-small…
LCRF.org
December 2, 2025 at 5:30 PM
scientiasocial.bsky.social
Professor David Gerbing’s new method cuts through the noise simplifying how we visualise data so patterns and insights become obvious at a glance. Discover more: www.scientia.global/professor-da... #DataViz #ScienceMadeSimple
Professor David Gerbing | A Quick and Easy New Way to Visualise Data • scientia.global
Do you find data analysis dense and impenetrable, like a quantitative jungle? You’re not alone. Many of the most useful statistical tools have steep-learning curves and often demand both sophisticated...
www.scientia.global
October 9, 2025 at 10:01 AM
lcrf.org
#ScienceMadeSimple - The FDA granted accelerated approval to sunvozertinib as a treatment for EGFR exon 20+ #LungCancer. LCRF's Chief Scientific Officer, Dr. Toni Wozniak, explains what this means. LCRF.org/sms250825
Sunvozertinib for EGFR Exon 20+ NSCLC - Lung Cancer Research Foundation
The good news The U.S. Food and Drug Administration (FDA) has granted accelerated approval to sunvozertinib for the treatment of adult patients with advanced or metastatic non-small cell lung cancer…
LCRF.org
August 25, 2025 at 7:27 PM
good2knowso.bsky.social
Your eyes clean themselves over 20,000 times a day without you noticing!

#HiddenBodyFacts #EyeHealth #BodySecrets #CoolBodyFacts #ScienceMadeSimple #DidYouKnowThis #Good2KnowSo
August 7, 2025 at 12:02 PM
scivr.bsky.social
🧠 Science that sticks!

Studies show students retain more when they’re actively engaged. SCIVR’s VR modules help learners understand tough concepts in a fun, hands-on way.

#ScienceMadeSimple #EdTechTools #FutureOfEducation
July 30, 2025 at 2:28 PM
lcrf.org
Results from the NeoADAURA trial, which explores using targeted therapy before surgery in early stage #LungCancer, were recently presented at #ASCO25. LCRF's Chief Scientific Officer Dr. Antoinette Wozniak, explains what we know so far. LCRF.org/sms250728
#ScienceMadeSimple
July 28, 2025 at 6:50 PM
scaientist.bsky.social
Fun Fact time!🎉

Teachers have used illustrated comics to simplify chemistry concepts like the periodic table, making complex formulas feel less intimidating.⚛️🤩

ScAIentist builds on that approach—helping make complex topics more fun!✨

#VisualEducation #ScienceMadeSimple #ScAIentist #fff #funfact
June 13, 2025 at 12:43 PM
brettvhaafc.bsky.social
To understand the potential of wetlands to mitigate climate change, Dr. Murray and her team regularly measure greenhouse gas emissions in wetlands with a #ScienceMadeSimple, but clever device called a floating chamber. 3/
June 5, 2025 at 5:16 PM
colleenchanel.bsky.social
To understand the potential of wetlands to mitigate climate change, Dr. Murray and her team regularly measure greenhouse gas emissions in wetlands with a #ScienceMadeSimple, but clever device called a floating chamber.
Learn more about Dr. Murray’s research: ow.ly/vFEt50W2vX1 #EnviroWeek
Going with the flow: AAFC's newest Prince Edward Island scientist researching natural solutions for sustainable water - agriculture.canada.ca
ow.ly
June 2, 2025 at 1:48 PM
sciencemadesimple.bsky.social
This week is incredibly hectic as our presenters are traveling extensively to visit numerous schools around the UK.
Hathaway Academy, WilliamHowardSchool, Mayfield School in Dagenham, George Dixon Academy, Ysgol Madras, Ysgol Gymraeg Pum Hel & Ysgol Gymraeg Caerffili
#STEMFun #sciencemadesimple
May 5, 2025 at 8:28 AM
lcrf.org
The FDA approved larotrectinib (Vitrakvi) for adult and pediatric patients with NTRK gene fusion-positive solid tumors. LCRF's Chief Scientific Officer, Antoinette Wozniak, MD, explains what this means. #ScienceMadeSimple #Lung Cancer LCRF.org/sms250424
Science Made Simple: drug approval for NTRK - Lung Cancer Research Foundation
The good news The Food and Drug Administration (FDA) approved larotrectinib (Vitrakvi) for adult and pediatric patients with NTRK gene fusion-positive solid tumors. Why it’s important Neurotrophic…
lcrf.org
May 2, 2025 at 5:03 PM
lcrf.org
The FDA approved larotrectinib for adult and pediatric patients with NTRK gene fusion-positive cancer tumors. What does this mean? LCRF's Chief Scientific Officer, Dr. Antoinette Wozniak, explains: LCRF.org/sms250424 #LungCancer #ScienceMadeSimple
Science Made Simple: drug approval for NTRK - Lung Cancer Research Foundation
The good news The Food and Drug Administration (FDA) approved larotrectinib (Vitrakvi) for adult and pediatric patients with NTRK gene fusion-positive solid tumors. Why it’s important Neurotrophic…
LCRF.org
April 24, 2025 at 7:00 PM
reutavinun.bsky.social
1/12 Let's talk about two recent breastfeeding studies that might be causing unnecessary alarm for parents. I'm breaking it down so you don't have to panic! #ParentingFacts #BabyFeeding #ScienceMadeSimple 🧵
April 9, 2025 at 6:08 PM
jellypodai.bsky.social
Dr. Louise Lambert shares why making science simple matters. Watch as Jellypod turns intricate research into clear, engaging podcasts—her free resource for everyone.

#ScienceMadeSimple #Jellypod #Podcasting
March 25, 2025 at 9:48 PM
wedocrispr.bsky.social
CRISPR-based technologies are famous for their ability to edit the DNA. But did you know that we can also use CRISPR to edit the RNA? Wanna learn how RNA editing works? Check out our explainer! #CRISPR #RNAediting #geneediting #sciencecommunication #sciencemadesimple #genomeediting
WeDoCRISPR on LinkedIn: RNA Editing
CRISPR-based technologies are famous for their ability to edit the DNA. But did you know that we can also use CRISPR to edit the RNA? RNA is like a photocopy…
www.linkedin.com
February 18, 2025 at 9:36 AM
steptofusion.bsky.social
...from fusion and further demonstrate the path to commercialisation of fusion energy.

#FusionUnwrapped #ScienceMadeSimple #EnergyExplained

*Curious about fusion or STEP? Follow us for more facts.* 2/2
January 4, 2025 at 2:00 PM